Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-008409

Exec. VP, European Commercial sold 13,135 shares at $9.06 ($119,010)

  • Exec. VP, European Commercial acquired 13,135 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Daniell Richard · Exec. VP, European Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-09 Exercise or conversion : show line 1 in the form +13,135 33,415 D
2022-02-09 Sale : show line 2 in the form −13,135 $9.06 $119,010 20,280 D
Open-market sales · 13,135 sh · avg $9.06 · $119,010

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-02-09 Exercise or conversion : show line 3 in the form Restricted Share Units −13,135 0 D
2022-02-08 Grant or award : show line 4 in the form Restricted Share Units +43,358 43,358 D
Loading xslF345X03/doc4.xml…